Annovis Bio ANVS
NYSE ANVS
$1.17 +0.01 (+0.86%)
At close: Oct 2, 2026 · 4:00 PM EDT

Annovis Bio (ANVS) Other Accumulated Expenses (2019)

Updated

Annovis Bio (ANVS) posted Other Accumulated Expenses of $36,041 for Q4 2019.

Analysis

Annovis Bio (ANVS) Other Accumulated Expenses (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Annovis Bio 49.85 Mn 49.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 36,041.00
API Access

Annovis Bio Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ANVS&period=max&api_key=YOUR_API_KEY